Neil Klompas - 17 Oct 2025 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Director
Signature
/s/ Eric A Adams, attorney-in-fact for Mr. Neil Klompas
Issuer symbol
INM
Transactions as of
17 Oct 2025
Transactions value $
$0
Form type
4
Filing time
21 Oct 2025, 13:58:38 UTC
Previous filing
17 Oct 2025
Next filing
19 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Klompas Neil A Director C/O INMED PHARMACEUTICALS INC., 1445-885 WEST GEORGIA ST., VANCOUVER, BRITISH COLUMBIA, CANADA /s/ Eric A Adams, attorney-in-fact for Mr. Neil Klompas 21 Oct 2025 0001761857

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Right to Buy) Award $0 +3,500 $0 3,500 17 Oct 2025 Common shares 3,500 $2.1 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 (1) The options were granted on Oct 17, 2025 and will vest monthly, in arrears, as follows: (i) 98 stock options will vest on the 17th day of each month for 35 months, and (ii) 70 stock options will vest on Oct 17, 2025 (the three year anniversary of Grant date).